Nori Ebersole is a proven Human Resources executive with a successful record of building high-performing teams at growth companies and achieving compelling results for companies and their people.

Ms. Ebersole served as the Chief People Officer at Prometheus Biosciences from March 2021 through the company’s sale to Merck in 2023. Ms. Ebersole led the talent acquisition ramp up and, under her leadership, Prometheus Biosciences was recognized as a 2023 Fortune Best Workplaces in BioPharma.

Prior to joining Prometheus Biosciences, Ms. Ebersole served as EVP & Chief Human Resources Officer for Urovant Sciences, Inc. from 2017 to 2021, through Urovant’s IPO and subsequent take-private merger with Sumitomo Dainippon at a significant premium. Prior to Urovant, she was the Chief Human Resources Officer at Paul Hastings, LLP. Ms. Ebersole also served an 18-year tenure at Allergan Inc., through their sale to Actavis for $70.5 billion.

Ms. Ebersole holds a B.S. in Business Administration from the University of Southern California Marshall School of Business.